107 related articles for article (PubMed ID: 28183747)
1. T-cell rosettes in nodular lymphocyte-predominant Hodgkin lymphoma.
Nguyen HL; Kelley TW
Blood; 2017 Feb; 129(6):802. PubMed ID: 28183747
[No Abstract] [Full Text] [Related]
2. Intranodular clusters of activated cells with T follicular helper phenotype in nodular lymphocyte predominant Hodgkin lymphoma: a pilot study of 32 cases from Finland.
Nathwani BN; Vornanen M; Winkelmann R; Kansal R; Doering C; Hartmann S; Hansmann ML
Hum Pathol; 2013 Sep; 44(9):1737-46. PubMed ID: 23684509
[TBL] [Abstract][Full Text] [Related]
3. Increased programmed death-1+ tumor-infiltrating lymphocytes in classical Hodgkin lymphoma substantiate reduced overall survival.
Muenst S; Hoeller S; Dirnhofer S; Tzankov A
Hum Pathol; 2009 Dec; 40(12):1715-22. PubMed ID: 19695683
[TBL] [Abstract][Full Text] [Related]
4. B-cell transcription factors Pax-5, Oct-2, BOB.1, Bcl-6, and MUM1 are useful markers for the diagnosis of nodular lymphocyte predominant Hodgkin lymphoma.
Herbeck R; Teodorescu Brînzeu D; Giubelan M; Lazăr E; Dema A; Ioniţă H
Rom J Morphol Embryol; 2011; 52(1):69-74. PubMed ID: 21424034
[TBL] [Abstract][Full Text] [Related]
5. [Differential diagnosis of nodular lymphocyte-predominant Hodgkin lymphoma and lymphocyte-rich classic Hodgkin lymphoma: role of immunohistochemistry].
He YM; Li GD; Li FY; Jiang W; Ji H; Liao DY; Liu WP; Li YC; Li WF; Chen Y; Yang YH; Wang SX; Yang ZR
Zhonghua Bing Li Xue Za Zhi; 2007 Jun; 36(6):416-7. PubMed ID: 17822631
[No Abstract] [Full Text] [Related]
6. Lymphocyte predominant cells of nodular lymphocyte predominant Hodgkin lymphoma interact with rosetting T cells in an immunological synapse.
Bein J; Thurner L; Hansmann ML; Hartmann S
Am J Hematol; 2020 Dec; 95(12):1495-1502. PubMed ID: 32815561
[TBL] [Abstract][Full Text] [Related]
7. Intracellular cytokine profiles by peripheral blood CD3+ T-cells in patients with classical Hodgkin lymphoma.
Mainou-Fowler T; Taylor PR; Miller S; Dickinson AM; Proctor SJ
Leuk Lymphoma; 2003 Aug; 44(8):1325-31. PubMed ID: 12952225
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the Microenvironment of Nodular Lymphocyte Predominant Hodgkin Lymphoma.
Visser L; Rutgers B; Diepstra A; van den Berg A; Sattarzadeh A
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999289
[TBL] [Abstract][Full Text] [Related]
9. Expression of TIA1 and PAX5 in Classical Hodgkin Lymphoma at Initial Diagnosis May Predict Clinical Outcome.
Nguyen TT; Frater JL; Klein J; Chen L; Bartlett NL; Foyil KV; Kreisel FH
Appl Immunohistochem Mol Morphol; 2016 Jul; 24(6):383-91. PubMed ID: 26067141
[TBL] [Abstract][Full Text] [Related]
10. Case Study Interpretation--Houston: Case 2. Classical Hodgkin lymphoma.
Olteanu H
Cytometry B Clin Cytom; 2011; 80(4):258-60. PubMed ID: 21638769
[No Abstract] [Full Text] [Related]
11. High-grade transformation in nodular lymphocyte predominant Hodgkin lymphoma.
Nayak SS; Parthiban SK; Paul P; Gujral S
Indian J Pathol Microbiol; 2020; 63(3):503-505. PubMed ID: 32769356
[No Abstract] [Full Text] [Related]
12. Nodular lymphocyte predominant Hodgkin lymphoma. An immunophenotypic reappraisal based on a single-institution experience.
Uherova P; Valdez R; Ross CW; Schnitzer B; Finn WG
Am J Clin Pathol; 2003 Feb; 119(2):192-8. PubMed ID: 12579988
[TBL] [Abstract][Full Text] [Related]
13. Follicular peripheral T-cell lymphoma expands the spectrum of classical Hodgkin lymphoma mimics.
Moroch J; Copie-Bergman C; de Leval L; Plonquet A; Martin-Garcia N; Delfau-Larue MH; Molinier-Frenkel V; Belhadj K; Haioun C; Audouin J; Swerdlow SH; Marafioti T; Gaulard P
Am J Surg Pathol; 2012 Nov; 36(11):1636-46. PubMed ID: 23073322
[TBL] [Abstract][Full Text] [Related]
14. PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma.
Nam-Cha SH; Roncador G; Sanchez-Verde L; Montes-Moreno S; Acevedo A; Domínguez-Franjo P; Piris MA
Am J Surg Pathol; 2008 Aug; 32(8):1252-7. PubMed ID: 18594468
[TBL] [Abstract][Full Text] [Related]
15. Hodgkin's lymphoma associated T-cells exhibit a transcription factor profile consistent with distinct lymphoid compartments.
Atayar C; van den Berg A; Blokzijl T; Boot M; Gascoyne RD; Visser L; Poppema S
J Clin Pathol; 2007 Oct; 60(10):1092-7. PubMed ID: 17158640
[TBL] [Abstract][Full Text] [Related]
16. Programmed death 1 expression in variant immunoarchitectural patterns of nodular lymphocyte predominant Hodgkin lymphoma: comparison with CD57 and lymphomas in the differential diagnosis.
Churchill HR; Roncador G; Warnke RA; Natkunam Y
Hum Pathol; 2010 Dec; 41(12):1726-34. PubMed ID: 20825974
[TBL] [Abstract][Full Text] [Related]
17. Intrafollicular classical Hodgkin lymphoma mimicking nodular lymphocyte predominant Hodgkin lymphoma: a report of two cases.
Tatsuno M; Maeshima AM; Kim SW; Maruyama D; Taniguchi H; Miyamoto K; Fukuhara S; Kobayashi Y; Tobinai K; Kushima R
Pathol Int; 2014 Dec; 64(12):613-7. PubMed ID: 25394195
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Pax5 expression and comparison with BLA.36 and CD79αcy in feline non-Hodgkin lymphoma.
Felisberto R; Matos J; Alves M; Cabeçadas J; Henriques J
Vet Comp Oncol; 2017 Dec; 15(4):1257-1268. PubMed ID: 27549353
[TBL] [Abstract][Full Text] [Related]
19. Use of an expanded immunohistochemical panel to distinguish cutaneous Hodgkin lymphoma from histopathologic imitators.
Cho RJ; McCalmont TH; Ai WZ; Fox LP; Treseler P; Pincus LB
J Cutan Pathol; 2012 Jun; 39(6):651-8. PubMed ID: 22324490
[TBL] [Abstract][Full Text] [Related]
20. Histopathological features and their prognostic impact in nodular lymphocyte-predominant Hodgkin lymphoma--a matched pair analysis from the German Hodgkin Study Group (GHSG).
Hartmann S; Eichenauer DA; Plütschow A; Mottok A; Bob R; Koch K; Bernd HW; Cogliatti S; Hummel M; Feller AC; Ott G; Möller P; Rosenwald A; Stein H; Hansmann ML; Engert A; Klapper W
Br J Haematol; 2014 Oct; 167(2):238-42. PubMed ID: 24965443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
